© 2022 MJH Life Sciences and Cancer Network. All rights reserved.
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
October 23, 2019
The VOLFI trial enrolled 105 patients with RAS wild-type metastatic colorectal cancer.
October 22, 2019
A combination of trifluridine and tipiracil showed some gains in overall survival for patients with metastatic gastric cancer or gastroesophageal junction cancer.
October 18, 2019
Combination therapy with nivolumab and bevacizumab appeared to have clinical activity in ovarian cancer patients with platinum-sensitive or platinum-resistant disease.
October 17, 2019
BRAF and MEK inhibitors appear to have clinical activity in patients with metastatic melanoma with rare BRAF mutations.
October 16, 2019
A new study looked at the characteristics of diagnosed breast cancer cases in San Francisco.
October 15, 2019
A study showed patients seem to lack an understanding of the meaning of progression-free survival.
October 09, 2019
The study found patients with lung cancer referred to palliative care earlier lived longer.
October 08, 2019
The results of the TAILORx trial went against previous ideas that breast cancer patients with a high Oncotype score who needed chemotherapy and endocrine therapy wouldn't fare well.
October 02, 2019
Adding PARP inhibitors to maintenance therapy was shown to prolong progression-free survival in patients with advanced ovarian cancer.
Maintenance therapy with niraparib may improve survival in patients with ovarian cancer.